Viewing Study NCT05949593


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-01-07 @ 2:53 AM
Study NCT ID: NCT05949593
Status: RECRUITING
Last Update Posted: 2025-02-14
First Post: 2023-07-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy
Sponsor: Belite Bio, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module